Ledger.Open graph →

SEC Form D · filed February 5, 2021

Cerecin Inc

Offering

$15.0M

Sold

$10.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

DENVER, CO

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Joseph S. Zakrzewski · Denver, CODirector Gurpreet S. Vohra · Denver, CODirector Charles Stacey · Denver, COExec · Director Jerris T. Knaisch · Denver, COExec Hans-Jurgen S. Woerle · Denver, CODirector Claude T. Nash · Denver, CODirector Wolfgang T. Reichenberger · Denver, CODirector Samuel T. Henderson · Denver, COExec Daniel Pickering · Houston, TXDirector Yossi Shemesh · Kadima, L3Director Robert Ferriol · Portland, ORExec · Director Oluwaseun Oyinsan · Millbury, MAExec Noah Hershcoviz · Kadima, L3Director Doron Cohen · Kadima, L3Director Boaz Gorfung · Kadima, L3Exec Walker Moody · Houston, TXDirector Nayel M. Nassar · Denver, CODirector Aurora R. Cassirer · Elmsford, NYDirector Maria R. Schroeder · Elmsford, NYExec Peter Kim · Irvine, CAExec Pranay Parikh · Irvine, CADirector Mithulan Jegapragasan · Irvine, CADirector Jeffrey Harris · Boca Raton, FLDirector Sergey Sherman · Boca Raton, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗